K

Vesalius Biocapital logo

Vesalius Biocapital

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Series C

Inflammatix logo
Inflammatix

Molecular diagnostics • Acute infection

Think.Health logo
Vesalius BioCapital logo
RAW Ventures logo
OSF Healthcare logo

Inflammatix develops molecular diagnostic tests, including the TriVerity™ Acute Infection and Sepsis Test, to improve the detection and treatment of sepsis in emergency departments.

Series E
$57M
09/12/2024
Article
Caresyntax logo
Caresyntax

AI-enabled • Surgical software

Symbiotic Capital logo
Relyens Group logo
ProAssurance logo
Plug & Play logo

Caresyntax develops AI-enabled surgical software that enhances surgical outcomes by integrating and analyzing comprehensive data to support real-time and post-surgical decision-making.

Hybrid C
$180M
08/16/2024
Article
Memo Therapeutics logo
Memo Therapeutics

Biotech • Late-Stage

Vesalius Biocapital logo
Verve Ventures logo
Swisscanto logo
Schroders Capital logo

Memo Therapeutics is a late-stage biotech company that has raised CHF 25M in a Series C funding round to develop its antibody, AntiBKV, and advance its existing antibody pipeline.

Series C
$27.6M
11/02/2023
Article